Aldeyra Therapeutics, Inc.
(NASDAQ : ALDX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.20%83.100.9%$974.49m
KITEKite Pharma, Inc.
0.01%179.3216.1%$742.16m
CELGCelgene Corporation
0.40%144.471.1%$499.74m
AMGNAmgen Inc.
0.03%185.821.1%$483.32m
BIIBBiogen Inc.
-0.17%317.911.2%$421.63m
REGNRegeneron Pharmaceuticals, Inc.
1.46%439.022.7%$359.50m
ALNYAlnylam Pharmaceuticals, Inc
1.49%115.5010.7%$249.40m
ALXNAlexion Pharmaceuticals, Inc.
0.45%143.461.9%$230.00m
JUNOJuno Therapeutics, Inc.
-5.01%42.8814.6%$224.90m
VRTXVertex Pharmaceuticals Incorporated
-1.41%149.131.9%$208.39m
INCYIncyte Corporation
-1.27%109.442.6%$205.01m
ILMNIllumina, Inc.
-0.66%200.083.5%$158.36m
BLUEBluebird Bio, Inc.
1.05%130.1019.3%$142.93m
BMRNBioMarin Pharmaceutical Inc.
-0.85%94.154.4%$136.23m
CLVSClovis Oncology, Inc.
-2.85%76.3218.0%$132.55m

Company Profile

Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.